Cargando…

Predictive computational modeling to define effective treatment strategies for bone metastatic prostate cancer

The ability to rapidly assess the efficacy of therapeutic strategies for incurable bone metastatic prostate cancer is an urgent need. Pre-clinical in vivo models are limited in their ability to define the temporal effects of therapies on simultaneous multicellular interactions in the cancer-bone mic...

Descripción completa

Detalles Bibliográficos
Autores principales:	Cook, Leah M., Araujo, Arturo, Pow-Sang, Julio M., Budzevich, Mikalai M., Basanta, David, Lynch, Conor C.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Nature Publishing Group 2016
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4944130/ https://www.ncbi.nlm.nih.gov/pubmed/27411810 http://dx.doi.org/10.1038/srep29384

Ejemplares similares

Quantification and Optimization of Standard-of-Care Therapy to Delay the Emergence of Resistant Bone Metastatic Prostate Cancer
por: Araujo, Arturo, et al.
Publicado: (2021)

Fractionated follow-up chemotherapy delays the onset of resistance in bone metastatic prostate cancer
por: Warman, Pranav I., et al.
Publicado: (2018)

Osteoid cell-derived chemokines drive bone-metastatic prostate cancer
por: Johnson, Catherine S., et al.
Publicado: (2023)

Mesenchymal stem cell-derived interleukin-28 drives the selection of apoptosis resistant bone metastatic prostate cancer
por: McGuire, Jeremy J., et al.
Publicado: (2021)

Variability of Image Features Computed from Conventional and Respiratory-Gated PET/CT Images of Lung Cancer
por: Oliver, Jasmine A., et al.
Publicado: (2015)

Integrated computational and in vivo models reveal Key Insights into macrophage behavior during bone healing
por: Baratchart, Etienne, et al.
Publicado: (2022)

In Vivo Imaging of Rat Vascularity with FDG-Labeled Erythrocytes
por: Wang, Shaowei, et al.
Publicado: (2022)

Neutrophils are mediators of metastatic prostate cancer progression in bone
por: Costanzo-Garvey, Diane L., et al.
Publicado: (2020)

Biomarkers for prostate cancer: present challenges and future opportunities
por: Sharma, Pranav, et al.
Publicado: (2015)

A Monte Carlo Method for Determining the Response Relationship between Two Commonly Used Detectors to Indirectly Measure Alpha Particle Radiation Activity
por: Tichacek, Christopher J., et al.
Publicado: (2019)

Imaging metastatic bone disease from carcinoma of the prostate
por: Messiou, C, et al.
Publicado: (2009)

Computational modeling reveals a key role for polarized myeloid cells in controlling osteoclast activity during bone injury repair
por: Lo, Chen Hao, et al.
Publicado: (2021)

Evaluation of radiofluorinated carboximidamides as potential IDO-targeted PET tracers for cancer imaging
por: Huang, Xuan, et al.
Publicado: (2017)

In vivo positron emission tomographic blood pool imaging in an immunodeficient mouse model using 18F-fluorodeoxyglucose labeled human erythrocytes
por: Choi, Jung W., et al.
Publicado: (2019)

Evaluation of bone metastatic burden by bone SPECT/CT in metastatic prostate cancer patients: defining threshold value for total bone uptake and assessment in radium-223 treated patients
por: Umeda, Takuro, et al.
Publicado: (2017)

γδ-Enriched CAR-T cell therapy for bone metastatic castrate-resistant prostate cancer
por: Frieling, Jeremy S., et al.
Publicado: (2023)

Radiological semantics discriminate clinically significant grade prostate cancer
por: Li, Qian, et al.
Publicado: (2019)

Defining Young in the Context of Prostate Cancer
por: Chambers, Suzanne K., et al.
Publicado: (2015)

Translational Strategies to Target Metastatic Bone Disease
por: Pagnotti, Gabriel M., et al.
Publicado: (2022)

Preliminary Therapy Evaluation of (225)Ac-DOTA-c(RGDyK) Demonstrates that Cerenkov Radiation Derived from (225)Ac Daughter Decay Can Be Detected by Optical Imaging for In Vivo Tumor Visualization
por: Pandya, Darpan N., et al.
Publicado: (2016)

Habitats in DCE-MRI to Predict Clinically Significant Prostate Cancers
por: Parra, Nestor Andres, et al.
Publicado: (2019)

Prostate cancer addiction to oxidative stress defines sensitivity to anti-tumor neutrophils
por: Costanzo-Garvey, Diane L., et al.
Publicado: (2022)

Treatment results of radiotherapy to both the prostate and metastatic sites in patients with bone metastatic prostate cancer
por: Inaba, Koji, et al.
Publicado: (2021)

Animal models of bone metastatic prostate cancer
por: Tae, Jong Hyun, et al.
Publicado: (2023)

Defining aggressive prostate cancer: a geospatial perspective
por: Wiese, Daniel, et al.
Publicado: (2023)

Endothelial Cells as Precursors for Osteoblasts in the Metastatic Prostate Cancer Bone
por: Paiva, Ana E., et al.
Publicado: (2017)

A phase II randomized clinical trial using aglycone isoflavones to treat patients with localized prostate cancer in the pre-surgical period prior to radical prostatectomy
por: Kumar, Nagi B., et al.
Publicado: (2020)

Bone scan positivity in non-metastatic, castrate-resistant prostate cancer: external validation study
por: Johnston, Ashley W., et al.
Publicado: (2020)

Green tea extract for prevention of prostate cancer progression in patients on active surveillance
por: Kumar, Nagi B., et al.
Publicado: (2018)

Plasma-seq: a novel strategy for metastatic prostate cancer analysis
por: Farris, Caitlin, et al.
Publicado: (2013)

African‐American men and prostate cancer‐specific mortality: a competing risk analysis of a large institutional cohort, 1989–2015
por: Williams, Vonetta L., et al.
Publicado: (2018)

Wnt Signaling Drives Prostate Cancer Bone Metastatic Tropism and Invasion()
por: Wang, Yugang, et al.
Publicado: (2020)

Phase I dose escalation trial of stereotactic radiotherapy prior to robotic prostatectomy in high risk prostate cancer
por: Liveringhouse, Casey, et al.
Publicado: (2021)

Laparoscopic Extraperitoneal Radical Prostatectomy: Impact of the Learning Curve on Perioperative Outcomes and Margin Status
por: Rodriguez, Alejandro R., et al.
Publicado: (2010)

Variation in HNF1B and Obesity May Influence Prostate Cancer Risk in African American Men: A Pilot Study
por: Chornokur, Ganna, et al.
Publicado: (2013)

Association of Bone Metastatic Burden With Survival Benefit From Prostate Radiotherapy in Patients With Newly Diagnosed Metastatic Prostate Cancer: A Secondary Analysis of a Randomized Clinical Trial
por: Ali, Adnan, et al.
Publicado: (2021)

Bone morphogenetic protein pathway responses and alterations of osteogenesis in metastatic prostate cancers
por: Provera, Meredith D., et al.
Publicado: (2022)

Targeting Bone Metastases in Metastatic Castration-Resistant Prostate Cancer
por: El-Amm, Joelle, et al.
Publicado: (2016)

Liver uptake on bone scan for prostate cancer metastatic workup
por: Mukendi, Alain Mwamba
Publicado: (2019)

Effects of Green Tea Catechins on Prostate Cancer Chemoprevention: The Role of the Gut Microbiome
por: Kumar, Nagi B., et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_5qpornu6jnufhpj5p95qiqf658